|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.990 HKD | -1.27% |
|
-3.44% | -16.84% |
| 06-16 | CSPC Pharmaceutical Marketing Application for Hypertension Drug Accepted in China | MT |
| 06-15 | CSPC Pharmaceutical's Paclitaxel Cancer Drug Wins Marketing Approval in China | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSPC PHARMACEUTICAL GROUP LIMITED | Other Pharmaceuticals | -1.27% | -3.44% | -16.84% | -14.41% | -41.09% | 10.33B |  | | |
- Stock Market
- Stocks
- 1093 Stock
- Charts CSPC Pharmaceutical Group Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
